BriefCase-Triage

K251195

Aidoc Medical , Ltd. · cleared 2026-01-27 · product code QAS · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.5)
Briefcase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linux-based server in a cloud environment.
Algorithmartificial intelligence, deep-learning algorithms
source quote (p.6)
Both devices are artificial intelligence, deep-learning algorithms incorporated in software packages for use with DICOM compliant CT scanners, PACS, and radiology workstations.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.13)
Cybersecurity has been incorporated into the software development lifecycle in alignment with Section 524B of the FD&C Act and FDA cybersecurity guidance.

Validation studies (1)

Retrospective clinical

n=544 cases · 6 site(s)

endpoints: sensitivity; specificity; BriefCase-Triage time-to-notification; Positive Predictive Value (PPV); Negative Predictive Value (NPV); Positive Likelihood Ratio (PLR); Negative Likelihood Ratio (NLR)

Reported performance (7 observations)

sensitivity87.8CI 83.1%, 91.6%
source quote (p.10)
For the primary endpoint, sensitivity was 87.8% (95% CI: 83.1%, 91.6%) and specificity was 91.6% (95% CI: 87.9%, 94.5%), meeting the study’s primary endpoint.
specificity91.6CI 87.9%, 94.5%
source quote (p.10)
For the primary endpoint, sensitivity was 87.8% (95% CI: 83.1%, 91.6%) and specificity was 91.6% (95% CI: 87.9%, 94.5%), meeting the study’s primary endpoint.
npvas written: “NPV98.9CI 98.4%-99.2%
source quote (p.11)
NPV was 98.9% (95% CI: 98.4%-99.2%) and PPV was 47.6% (95% CI: 38.4%-57.1%).
ppvas written: “PPV47.6CI 38.4%-57.1%
source quote (p.11)
NPV was 98.9% (95% CI: 98.4%-99.2%) and PPV was 47.6% (95% CI: 38.4%-57.1%).
ppvas written: “PLR10.5CI 7.2-15.3
source quote (p.11)
PLR was 10.5 (95% CI: 7.2-15.3) and NLR was 0.13 (95% CI: 0.1-0.19).
npvas written: “NLR0.13CI 0.1-0.19
source quote (p.11)
PLR was 10.5 (95% CI: 7.2-15.3) and NLR was 0.13 (95% CI: 0.1-0.19).
time_to_resultas written: “Mean Time-to-notification44.8CI 41.4-48.2
source quote (p.10)
The BriefCase-Triage mean timeto-notification for the subject BA triage was 44.8 seconds (95% CI: 41.4-48.2).

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
1
drift signals on this device
  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K253578 (decision 2026-02-26) from Aidoc Medical , Ltd. for a matching device line ("BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K253578

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K251195